Order Article Reprints

Marchica V, Toscani D, Corcione A, Bolzoni M, Storti P, Vescovini R, Ferretti E, Dalla Palma B, Vicario E, Accardi F, et al. Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients. Cancers. 2019; 11(3):321. https://doi.org/10.3390/cancers11030321

Marchica, Valentina, Denise Toscani, Anna Corcione, Marina Bolzoni, Paola Storti, Rosanna Vescovini, Elisa Ferretti, Benedetta Dalla Palma, Emanuela Vicario, Fabrizio Accardi, and et al. 2019. "Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients" Cancers 11, no. 3: 321. https://doi.org/10.3390/cancers11030321

Marchica, V., Toscani, D., Corcione, A., Bolzoni, M., Storti, P., Vescovini, R., Ferretti, E., Dalla Palma, B., Vicario, E., Accardi, F., Mancini, C., Martella, E., Ribatti, D., Vacca, A., Pistoia, V., & Giuliani, N. (2019). Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients. Cancers, 11(3), 321. https://doi.org/10.3390/cancers11030321